Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.81)
# 701
Out of 4,911 analysts
238
Total ratings
63.52%
Success rate
21.61%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Overweight | $283 → $306 | $264.96 | +15.49% | 17 | Jul 25, 2025 | |
| CNC Centene | Downgrades: Equal-Weight | $70 → $33 | $28.39 | +16.24% | 12 | Jul 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $563 → $374 | $281.06 | +33.07% | 17 | May 14, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $71 → $60 | $60.77 | -1.27% | 10 | Apr 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $176.93 | +4.00% | 22 | Feb 5, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $4.14 | +141.55% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $5.00 | +10.00% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $14.45 | -48.10% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $11.76 | +2.04% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $168.55 | -13.97% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $165.02 | +121.19% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $711.82 | -41.00% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $8.96 | +1,239.29% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $237.98 | +160.53% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $289.10 | +72.95% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $60.70 | +104.28% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $296.37 | +7.30% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $157.14 | -55.45% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $11.61 | +235.92% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $199.17 | -2.09% | 6 | Oct 21, 2020 |
Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283 → $306
Current: $264.96
Upside: +15.49%
Centene
Jul 10, 2025
Downgrades: Equal-Weight
Price Target: $70 → $33
Current: $28.39
Upside: +16.24%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $563 → $374
Current: $281.06
Upside: +33.07%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71 → $60
Current: $60.77
Upside: -1.27%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $176.93
Upside: +4.00%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $4.14
Upside: +141.55%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $5.00
Upside: +10.00%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $14.45
Upside: -48.10%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $11.76
Upside: +2.04%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $168.55
Upside: -13.97%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $165.02
Upside: +121.19%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $711.82
Upside: -41.00%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $8.96
Upside: +1,239.29%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $237.98
Upside: +160.53%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $289.10
Upside: +72.95%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $60.70
Upside: +104.28%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $296.37
Upside: +7.30%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $157.14
Upside: -55.45%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.61
Upside: +235.92%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $199.17
Upside: -2.09%